INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Compressed Gas Systems In Aseptic Manufacturing
Learn about compressed gas systems and why effectively identifying and managing the risks associated with these systems is critical for maintaining product quality and ensuring compliance with GMP.
-
Lyophilization To Enable Drug Products Containing Labile Molecules
Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.
-
UPLC Columns: Fundamentals, Chemistries, And Selected Small-Molecule Applications
Discover the fundamentals of UPLC columns and their diverse chemistries. Learn more about versatility in separating small-molecule analytes using reversed-phase and hydrophilic interaction techniques.
-
Ensure Sterility In Small-Batch Drug Production
Automation and sterility are critical for small-batch drug manufacturing. Learn how robotic isolators streamline vial filling, reduce contamination risk, and support advanced therapies with precision.
-
5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes5/23/2025
In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.
-
Enhancing Automated Environmental Monitoring In Gloveless Isolators1/7/2026
Explore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.
-
Selecting A Prefillable Syringe System With Confidence2/5/2026
Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.
-
Powering The Next Generation Of Drug Delivery Systems12/4/2025
Discover how pharmaceutical extrusion, including aseptic methods, enables advanced drug delivery systems, detailing the critical process controls required for success with complex and novel drug products.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer11/21/2024
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Process stability, high efficiency and customizable features are crucial issues related to glass packaging manufacturing. Our ampoule forming line perfectly matches these needs, guaranteeing the highest performance thanks to cutting-edge capabilities, such as its automatic inspection system and electric rotational oven, which provides higher product handling stability.
-
Designed to be used in research and small scale manufacturing settings, this technology is ideally sized to be used in existing isolators, RABS and bio-safety cabinets, providing 100% fill weight verification - Up to 360 containers/hour.
-
The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.
-
When you need to provide a clean, contained environment for the safe handling of powders in dispensing, weighing, sampling, or subdivision operations, our PharmAir booths are a highly effective option. Complete containment solutions based around an innovative range of Downflow Containment Booths that bring different features and benefits to your application. But all have one thing in common: they give a Guaranteed Working Environment.
-
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.